西藏药业：新活素医保最终结果请关注医保局通知及公司后续公告

Core Viewpoint - Tibet Pharmaceutical indicated that the final results regarding the new active substance's insurance coverage should be monitored through notifications from the medical insurance bureau and subsequent company announcements [2] Group 1 - The company responded to inquiries from researchers between November 1 and November 30 [2]